PSE (Pseudoephedrine)

Browse PSE (Pseudoephedrine) Content

FDA headquarters sign in Washington DC

The Annual Forecast for Planned Monograph Activities describes planned monograph activities that FDA intends to address over the ensuing three years.

Flask with Chemicals in Gloved Hand

Federal oversight by the FDA ensures that ingredients and chemical additives used in vital healthcare products available to consumers, like nonprescription drugs, dietary supplements, and medical devices, routinely undergo the most rigorous safety evaluations.

The Health In Hand Foundation’s mobile-friendly website, HealthInHand.org, provides consumers with easily accessible information and guidance on how to safely use, store, and dispose of self-care products.

CHPA is committed to advancing solutions to illegal sales that penalize criminals and ensure law-abiding consumers continue to have access to a wide range of treatment options, including nonprescription medicines containing PSE.

The bipartisan federal Combat Meth Epidemic Act strikes the proper policy balance between restricting pseudoephedrine access for illicit use without unduly burdening consumers seeking safe, effective cold relief. Therefore, state legislators should refrain from overriding federal guidelines requiring prescriptions for these legitimate over-the-counter medications.

Manufacturers have developed an anti-smurfing educational program for the retail setting that is voluntary and offered to retailers at no cost. The intent is to educate potential illegal purchasers about related criminal penalties and how the real-time, stop-sale system works.

Filter Results